You really want to know what kind of doctor he is! OK, this is from the
About Us page of mist-on.com. What his bio doesn't say is that he's not
a Dr. Pepper type, he's a diet coke addict.
Dr. Tom Laughlin
Dr. Laughlin is the president of both Laughlin Products, Inc. and Mist-On
Systems, Inc. He holds the dominant patent in the spray booth industry
along with 15 related patents.
His long-time dream of building an “automated human paint booth” became
reality in 1997 when Dr. Laughlin began a high-tech product-development
venture with a Dallas based tanning-superstore chain. The goal of that
venture was the market introduction of the first automated sunless
spray-booth. The venture was very successful. In 1999, Dr. Laughlin
licensed this chain to make and market their own specific design, which
they trademarked as Mystic Tan. Dr. Laughlin formed and licensed his own
company to make and market his preferred design, the Mist-On Tan booth.
He recently licensed one of his European distributors, Jean Paul’s
Tanning, to make and market its own design to the European market.
Dr. Laughlin graduated from University of Louisiana, Lafayette, in 1974
with a BS in Physics. He received his Ph.D. in Biophysics from Florida
State University in 1979. He served as a research associate at The Oak
Ridge National Laboratory in Oak Ridge, Tennessee until 1983, when he
became the Senior Biophysicist at the Southern Research Institute in
Birmingham, Alabama. In 1988, Dr. Laughlin was hired by Schering/Plough
in Memphis, Tennessee as Principal Scientist and Project Manager,
overseeing new product development and product improvement projects,
concentrating on footcare and skincare products with emphasis in topical
delivery in consumer products. Dr. Laughlin also worked to develop both
over-the-counter and Rx products, including wart-removers, antifungal
products, odor controllers and in-grown toenail relievers. In 1995 he
moved to Texas to join Johnson & Johnson to manage project teams in
development and 510k filing of new chemical disinfectants/sterilants for
medical applications. These were global projects with interactions with
sales, marketing production, R&D, regulatory and legal groups from
Europe, Japan, Australia, South Africa, and Canada.